OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis
Jerzy P. Szaflarski, Hervé Besson, Wendyl D’Souza, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3169-3185
Open Access | Times Cited: 6
Jerzy P. Szaflarski, Hervé Besson, Wendyl D’Souza, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3169-3185
Open Access | Times Cited: 6
Showing 6 citing articles:
Post-marketing Experience with Cenobamate in the Treatment of Focal Epilepsies: A Multicentre Cohort Study
Adam Strzelczyk, Felix von Podewils, Hajo M. Hamer, et al.
CNS Drugs (2025)
Open Access
Adam Strzelczyk, Felix von Podewils, Hajo M. Hamer, et al.
CNS Drugs (2025)
Open Access
First clinical post-approval, observational study to assess clinical safety and effectiveness of brivaracetam sustained-release formulation in real-life settings of India: BEAM study
Lakshmi Narasimhan Ranganathan, Girish R. Kulkarni, Ashutosh Kakkad, et al.
Seizure (2025) Vol. 125, pp. 132-139
Closed Access
Lakshmi Narasimhan Ranganathan, Girish R. Kulkarni, Ashutosh Kakkad, et al.
Seizure (2025) Vol. 125, pp. 132-139
Closed Access
Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy
Pavel Klein, Dimitrios Bourikas
Advances in Therapy (2024) Vol. 41, Iss. 7, pp. 2682-2699
Open Access | Times Cited: 3
Pavel Klein, Dimitrios Bourikas
Advances in Therapy (2024) Vol. 41, Iss. 7, pp. 2682-2699
Open Access | Times Cited: 3
Brivaracetam use in clinical practice: a Delphi consensus on its role as first add-on therapy in focal epilepsy and beyond
Simona Lattanzi, Valentina Chiesa, Giancarlo Di Gennaro, et al.
Neurological Sciences (2024) Vol. 45, Iss. 9, pp. 4519-4527
Open Access | Times Cited: 1
Simona Lattanzi, Valentina Chiesa, Giancarlo Di Gennaro, et al.
Neurological Sciences (2024) Vol. 45, Iss. 9, pp. 4519-4527
Open Access | Times Cited: 1
BRIVA‐ONE study: 12‐month outcomes of brivaracetam monotherapy in clinical practice
Vicente Villanueva, E. Villar, A Fernández-Cabrera, et al.
Epilepsia Open (2024)
Open Access
Vicente Villanueva, E. Villar, A Fernández-Cabrera, et al.
Epilepsia Open (2024)
Open Access
SERIOUS ADVERSE EFFECTS of SELECTED ANTISEIZURE MEDICATIONS USED for TREATMENT of FOCAL ONSET SEIZURES
Miloš Milosavljević, Slobodan Јаnkovic
Expert Opinion on Drug Safety (2024) Vol. 24, Iss. 2, pp. 129-143
Closed Access
Miloš Milosavljević, Slobodan Јаnkovic
Expert Opinion on Drug Safety (2024) Vol. 24, Iss. 2, pp. 129-143
Closed Access
